Word

REZNARE

Status

Pending

Status Code

732

Status Date

Thursday, April 25, 2024

Serial Number

97201460

Mark Type

4

Filing Date

Tuesday, January 4, 2022

Published for Opposition

Tuesday, October 18, 2022

Trademark Owner History

Pfizer Inc. - Owner At Publication

Classifications

5 Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations

Trademark Events

Jan 7, 2022

New Application Office Supplied Data Entered

Jan 7, 2022

New Application Entered

Sep 14, 2022

Assigned To Examiner

Sep 14, 2022

Approved For Pub - Principal Register

Sep 28, 2022

Notification Of Notice Of Publication E-Mailed

Oct 18, 2022

Published For Opposition

Oct 18, 2022

Official Gazette Publication Confirmation E-Mailed

Dec 13, 2022

Noa E-Mailed - Sou Required From Applicant

Mar 27, 2023

Teas Change Of Owner Address Received

Mar 27, 2023

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Mar 27, 2023

Attorney/Dom.Rep.Revoked And/Or Appointed

Mar 27, 2023

Teas Change Of Correspondence Received

Mar 27, 2023

Applicant/Correspondence Changes (Non-Responsive) Entered

May 15, 2023

Sou Teas Extension Received

May 15, 2023

Sou Extension 1 Filed

May 15, 2023

Sou Extension 1 Granted

May 17, 2023

Notice Of Approval Of Extension Request E-Mailed

Nov 2, 2023

Sou Teas Extension Received

Nov 2, 2023

Sou Extension 2 Filed

Nov 2, 2023

Sou Extension 2 Granted

Nov 4, 2023

Notice Of Approval Of Extension Request E-Mailed

Apr 25, 2024

Sou Teas Extension Received

Apr 25, 2024

Sou Extension 3 Filed

Apr 25, 2024

Sou Extension 3 Granted